Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2010-09-13

FDA Approved: SALONPAS PAIN RELIEF — Supplemental Application (Hisamitsu Pharmaceutical Co., Inc.)

View source ↗

Summary

FDA approved a supplemental application for SALONPAS PAIN RELIEF to modify labeling (menthol, methyl salicylate) by Hisamitsu Pharmaceutical Co., Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SALONPAS PAIN RELIEF (MENTHOL, METHYL SALICYLATE)

Snippet

SUPPL AP for SALONPAS PAIN RELIEF (MENTHOL, METHYL SALICYLATE)